Two Sigma Investments, LP Timber Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.24 - $0.39 $10,465 - $17,005
-43,605 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.28 - $0.41 $3,552 - $5,201
-12,686 Reduced 22.54%
43,605 $17,000
Q4 2021

Feb 14, 2022
BUY
$0.38 - $0.89 $16,022 - $37,526
42,165 Added 298.49%
56,291 $21,000
Q3 2021

Nov 15, 2021
BUY
$0.89 - $1.18 $12,572 - $16,668
14,126 New
14,126 $13,000

About Timber Pharmaceuticals, Inc.

TMBR Quotes by TradingView
  • Ticker TMBR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,524,992
  • Description
  • Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...
More about TMBR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email